131 related articles for article (PubMed ID: 9659276)
21. High-normal calcium (1.35 mmol/l) dialysate in patients on CAPD: efficient and safe long-term control of plasma calcium, phosphate, and parathyroid hormone.
Bro S; Brandi L; Olgaard K
Nephrol Dial Transplant; 1996 Aug; 11(8):1586-91. PubMed ID: 8856216
[TBL] [Abstract][Full Text] [Related]
22. A challenging case of hypercalcemia.
Luceri PM; Haenel LC
J Am Osteopath Assoc; 2013 Jun; 113(6):490-3. PubMed ID: 23739761
[TBL] [Abstract][Full Text] [Related]
23. Severe hypercalcemia caused by parathyroid hormone in a rectal cancer metastasis: a case report.
Brun VH; Knutsen E; Stenvold H; Halvorsen H
BMC Endocr Disord; 2021 Jan; 21(1):4. PubMed ID: 33413267
[TBL] [Abstract][Full Text] [Related]
24. Mixed hepato/cholangiocarcinoma with paraneoplastic hypercalcemia.
Maarouf A; Adham M; Scoazec JY; Partensky C
J Hepatobiliary Pancreat Surg; 2008; 15(2):224-7. PubMed ID: 18392720
[TBL] [Abstract][Full Text] [Related]
25. Malignant hypercalcaemia related to parathyroid hormone-related peptide (PTHrP) secretion from a metastatic pancreatic neuroendocrine tumour (NET).
Symington M; Davies L; Kaltsas G; Weickert MO
BMJ Case Rep; 2017 Mar; 2017():. PubMed ID: 28331027
[TBL] [Abstract][Full Text] [Related]
26. Anastrozole can cause severe hypercalcaemia mimicking primary hyperparathyroidism.
Järhult J
Breast Cancer; 2014 May; 21(3):379-81. PubMed ID: 21290264
[TBL] [Abstract][Full Text] [Related]
27. Paraneoplastic hypercalcemia in a patient with adenosquamous cancer of the colon.
Thompson JT; Paschold EH; Levine EA
Am Surg; 2001 Jun; 67(6):585-8. PubMed ID: 11409809
[TBL] [Abstract][Full Text] [Related]
28. Paraneoplastic hypercalcaemia in ovarian carcinoma.
Allan SG; Lockhart SP; Leonard RC; Smyth JF
Br Med J (Clin Res Ed); 1984 Jun; 288(6432):1714-5. PubMed ID: 6428510
[TBL] [Abstract][Full Text] [Related]
29. Denosumab is Effective for Controlling Serum Calcium Levels in Patients with Humoral Hypercalcemia of Malignancy Syndrome: A Case Report on Parathyroid Hormone-related Protein-producing Cholangiocarcinoma.
Ashihara N; Nakajima K; Nakamura Y; Kobayashi M; Shirahata K; Maeda C; Uehara T; Gomi D; Ito N
Intern Med; 2016; 55(23):3453-3457. PubMed ID: 27904108
[TBL] [Abstract][Full Text] [Related]
30. Severe hypercalcaemia in B-cell lymphoma: combined effects of PTH-rP, IL-6 and TNF.
Daroszewska A; Bucknall RC; Chu P; Fraser WD
Postgrad Med J; 1999 Nov; 75(889):672-4. PubMed ID: 10621879
[TBL] [Abstract][Full Text] [Related]
31. Adenosquamous carcinoma of the pancreas associated with humoral hypercalcemia of malignancy (HHM).
Kobayashi N; Higurashi T; Iida H; Mawatari H; Endo H; Nozaki Y; Tomimoto A; Yoneda K; Akiyama T; Fujita K; Takahashi H; Yoneda M; Inamori M; Abe Y; Kirikoshi H; Kubota K; Saito S; Ueno N; Nakajima A; Yamanaka S; Inayama Y
J Hepatobiliary Pancreat Surg; 2008; 15(5):531-5. PubMed ID: 18836809
[TBL] [Abstract][Full Text] [Related]
32. The use of an intact molecule parathyroid hormone assay in disorders of calcium metabolism.
Bicknell EJ; Van't Hoff W
Ann Clin Biochem; 1988 Jul; 25 ( Pt 4)():367-72. PubMed ID: 3063205
[TBL] [Abstract][Full Text] [Related]
33. Urine calcium and serum ionized calcium, total calcium and parathyroid hormone concentrations in the diagnosis of primary hyperparathyroidism and familial benign hypercalcaemia.
Gunn IR; Wallace JR
Ann Clin Biochem; 1992 Jan; 29 ( Pt 1)():52-8. PubMed ID: 1536526
[TBL] [Abstract][Full Text] [Related]
34. Very low or undetectable intact parathyroid hormone levels in patients with surgically verified parathyroid adenomas.
Bhadada SK; Cardenas M; Bhansali A; Mittal BR; Behera A; Chanukya GV; Nahar U; Rao DS
Clin Endocrinol (Oxf); 2008 Sep; 69(3):382-5. PubMed ID: 18284640
[TBL] [Abstract][Full Text] [Related]
35. Control of hypercalcaemia of parathyroid carcinoma by immunisation.
Bradwell AR; Harvey TC
Lancet; 1999 Jan; 353(9150):370-3. PubMed ID: 9950443
[TBL] [Abstract][Full Text] [Related]
36. [Determination of plasma parathyroid hormone in the differential diagnosis of hypercalcemias associated with malignant tumors].
Gasser AB; Burckhardt P
Schweiz Med Wochenschr; 1978 Jul; 108(27):1031-4. PubMed ID: 663597
[TBL] [Abstract][Full Text] [Related]
37. A survey of diagnoses in patients with a low intact parathyroid hormone concentration.
Manning EM; Fraser WD
Ann Clin Biochem; 1993 May; 30 ( Pt 3)():252-5. PubMed ID: 8517606
[TBL] [Abstract][Full Text] [Related]
38. [Epidemiology of hypercalcemia. Significance of the determination of intact parathyroid hormone for differential diagnosis].
Blind E; Raue F; Zisterer A; Kohl B; Ziegler R
Dtsch Med Wochenschr; 1990 Nov; 115(46):1739-45. PubMed ID: 2226185
[TBL] [Abstract][Full Text] [Related]
39. Twist on a classic: vitamin D and hypercalcaemia of malignancy.
Osorio JC; Jones MG; Schatz-Siemers N; Tang SJ
BMJ Case Rep; 2017 Nov; 2017():. PubMed ID: 29170170
[TBL] [Abstract][Full Text] [Related]
40. Associations of serum 25-hydroxyvitamin D with circulating PTH, phosphate and calcium in patients with primary hyperparathyroidism.
Jayasena CN; Modi M; Palazzo F; De Silva A; Donaldson M; Meeran K; Dhillo WS
Clin Endocrinol (Oxf); 2013 Jun; 78(6):838-43. PubMed ID: 23036072
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
